Correlation Between Takeda Pharmaceutical and Delivra Health

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Delivra Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Delivra Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Delivra Health Brands, you can compare the effects of market volatilities on Takeda Pharmaceutical and Delivra Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Delivra Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Delivra Health.

Diversification Opportunities for Takeda Pharmaceutical and Delivra Health

0.75

Correlation Coefficient

Takeda Pharmaceutical  Delivra Health

Poor diversification

The 3 months correlation between Takeda and Delivra is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Delivra Health Brands in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delivra Health Brands and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Delivra Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delivra Health Brands has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Delivra Health go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Delivra Health

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.11 times more return on investment than Delivra Health. However, Takeda Pharmaceutical Co is 9.41 times less risky than Delivra Health. It trades about -0.12 of its potential returns per unit of risk. Delivra Health Brands is currently generating about -0.03 per unit of risk. If you would invest  1,446  in Takeda Pharmaceutical Co on September 20, 2024 and sell it today you would lose (110.00) from holding Takeda Pharmaceutical Co or give up 7.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Delivra Health Brands

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Delivra Health Brands

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Delivra Health Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Takeda Pharmaceutical and Delivra Health

The main advantage of trading using opposite Takeda Pharmaceutical and Delivra Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Delivra Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delivra Health will offset losses from the drop in Delivra Health's long position.

The idea behind Takeda Pharmaceutical Co and Delivra Health Brands pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.